Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | FDPS | P14324 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL199267 | 0.97 | LMNA (0.54) | LMNAALDH1A1TDP1DNM1TSHR | |
| SCHEMBL103377 | 0.97 | LMNA (0.54) | LMNAALDH1A1TDP1DNM1TSHR | |
| SCHEMBL199590 | 0.97 | LMNA (0.54) | LMNAALDH1A1TDP1DNM1TSHR | |
| SCHEMBL103129 | 0.97 | LMNA (0.54) | LMNAALDH1A1TDP1DNM1TSHR | |
| SCHEMBL102015 | 0.97 | LMNA (0.54) | LMNAALDH1A1TDP1DNM1TSHR | |
| SCHEMBL201336 | 0.97 | LMNA (0.54) | LMNAALDH1A1TDP1DNM1TSHR | |
| SCHEMBL202269 | 0.97 | LMNA (0.54) | LMNAALDH1A1TDP1DNM1TSHR | |
| SCHEMBL202134 | 0.97 | LMNA (0.54) | LMNAALDH1A1TDP1DNM1TSHR | |
| SCHEMBL100621 | 0.97 | LMNA (0.54) | LMNAALDH1A1TDP1DNM1TSHR | |
| SCHEMBL101056 | 0.97 | LMNA (0.54) | LMNAALDH1A1TDP1DNM1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118201905-A | Cationic lipid | 武田药品工业株式会社 | 2024-06-14 | — | — | CN | disclosed |
| WO-2023085299-A1 | CATIONIC LIPID | 武田薬品工業株式会社 | 2023-05-19 | — | — | WO | disclosed |
| US-11495744-B2 | Organic semiconductor composition, organic thin film, and organic thin film transistor | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2022-11-08 | — | — | US | disclosed |
| CN-113200958-B | Phthalate ester organic photoelectric compound and preparation method and application thereof | 国家纳米科学中心 | 2022-08-05 | — | — | CN | disclosed |
| CN-108701768-B | Organic semiconductor composition, organic thin film comprising same, and use thereof | 国立研究开发法人产业技术综合研究所 | 2022-07-05 | — | — | CN | disclosed |
| US-11198698-B2 | Organic semiconductor composition, organic thin film comprising same, and use thereof | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2021-12-14 | — | — | US | disclosed |
| EP-3425687-B1 | ORGANIC SEMICONDUCTOR COMPOSITION, ORGANIC THIN FILM COMPRISING SAME, AND USE THEREOF | AIST (JP) | 2021-09-29 | — | — | EP | disclosed |
| CN-113200958-A | Phthalate ester organic photoelectric compound and preparation method and application thereof | 国家纳米科学中心 | 2021-08-03 | — | — | CN | disclosed |
| US-20200136061-A1 | Organic Semiconductor Composition, Organic Thin Film, and Organic Thin Film Transistor | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2020-04-30 | — | — | US | disclosed |
| EP-3608981-A1 | ORGANIC SEMICONDUCTOR COMPOSITION, ORGANIC THIN FILM AND ORGANIC THIN FILM TRANSISTOR | Nippon Kayaku Kabushiki Kaisha (JP) | 2020-02-12 | — | — | EP | disclosed |
| WO-2006110172-A2 | STEROID ANALOGS AND CHARACTERIZATION AND TREATMENT METHODS | HOLLIS-EDEN PHARMACEUTICALS.INC. (US) | 2006-10-19 | — | — | WO | disclosed |
| US-7094780-B1 | 3-aminoquinazolin-2,4-dione antibacterial agents | WARNER LAMBERT COMPANY LLC (US) | 2006-08-22 | — | — | US | disclosed |
| US-20060183762-A1 | 3-AMINOQUINAZOLIN-2,4-DIONE ANTIBACTERIAL AGENTS | ZOETIS WLC LLC | 2006-08-17 | — | — | US | disclosed |
| US-6548505-B1 | Protecting biological materials from damage caused by radiation; side effect reduction during radiotherapy or chemotherapy; indole, benzimidazole, benzoxazole or benzothiazole compounds substituted with 4-alkylpiperazino | PETER MACCALLUM CANCER INSTITUTE (AU) | 2003-04-15 | — | — | US | disclosed |
| EP-1255739-A1 | 3-AMINOQUINAZOLIN-2,4-DIONE ANTIBACTERIAL AGENTS | WARNER-LAMBERT COMPANY (US) | 2002-11-13 | — | — | EP | disclosed |
| WO-2001053273-A1 | 3-AMINOQUINAZOLIN-2,4-DIONE ANTIBACTERIAL AGENTS | WARNER-LAMBERT COMPANY (US) | 2001-07-26 | — | — | WO | disclosed |
| US-5280092-A | Emulsifier mixture of nonionic oil soluble surfactant and N-alkyl lactam | ISP INVESTMENTS INC. (US) | 1994-01-18 | — | — | US | disclosed |
| US-5216070-A | Using siloxane-emulsifier system for water-in-oil emulsion polymerization | ISP INVESTMENTS INC. (US) | 1993-06-01 | — | — | US | disclosed |
| US-5206316-A | For inverse emulsion polymerization; nonionic surfactant mixed with N-alkyl lactam or alkylated N-vinyl lactam polymer; cosmetics, thickeners | ISP INVESTMENTS INC. (US) | 1993-04-27 | — | — | US | disclosed |
| US-4128470-A | Supports for electrophoresis and process for the production of the same | FUJI PHOTO FILM CO., LTD. (JP) | 1978-12-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060183762-A1 | 3-AMINOQUINAZOLIN-2,4-DIONE ANTIBACTERIAL AGENTS | ABL1, NQO2, CBR3 | LMNA 3553/4885ALDH1A1 2259/4885TDP1 3071/4885 |
| US-11198698-B2 | Organic semiconductor composition, organic thin film comprising same, and use thereof | TST, TRMT1, OR10J3 | LMNA 4776/4885ALDH1A1 1350/4885TDP1 1685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.